Jump to content

Galen Partners

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Maurameir (talk | contribs) at 14:48, 17 March 2020 (Evolve Treatment Centers acquisition). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Galen Partners
IndustryPrivate Equity
Founded1990
HeadquartersStamford, Connecticut, U.S.
Key people
Philip Borden (Managing Director)

David Jahns (Managing Director)

Zubeen Shroff (Managing Director)
Websitewww.galen.com

Galen Partners is a leading healthcare-focused growth equity investment firm. With nearly $1 billion invested over five funds, Galen has helped build more than 70 companies since inception. Since its founding in 1990, Galen has created an investment portfolio with an aggregate market value of over $10 billion. The firm continues a tradition of strategic collaboration and partnership with Founders and management teams to build healthcare market leaders. Under the direction of the Managing Directors Philip Borden, David Jahns and Zubeen Shroff, Galen seeks to make investments in high-growth healthcare companies with revenues greater than $10 million and EBITDA between $0 and $9 million.[1]

In 2006, the company relocated its headquarters from New York City’s Rockefeller Center to Stamford, Connecticut.[1]

Portfolio Companies

Current and past investments include:[1][2][3][4]

References

  1. ^ a b c "Private Equity Company Relocates to Stamford". (October 4, 2006). Real Estate Weekly.
  2. ^ Monegain, Bernie (August 9, 2007) "Partners raises $250M to invest in healthcare IT". Healthcare IT News.
  3. ^ Kram, Barbara (October 2, 2009) "Galen Partners' David Jahns and Echoserve's Christopher Cone Talk About the MIH Merger". Dotmed News.
  4. ^ "Galen Partners, Portfolio Companies[permanent dead link]"
  5. ^ "Galen Partners acquires Los Angeles-based Evolve Treatment Centers". www.spglobal.com. Retrieved 2020-03-17.

External links